Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

被引:0
|
作者
Hui, C. [1 ]
Qu, V. [2 ]
Wang, J. Y. [2 ]
Von Eyben, R. [3 ]
Chang, Y. C. [4 ]
Chiang, P. L. [4 ]
Liang, C. H. [4 ]
Lin, J. Y. [4 ]
Lu, J. T. [4 ]
Li, G. [5 ]
Hayden, M. [5 ]
Myall, N. [6 ]
Soltys, S. G. [7 ]
Pollom, E. [3 ]
机构
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Radiat Oncol, Palo Alto, CA 94304 USA
[3] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[4] Vysioneer Inc, Cambridge, MA USA
[5] Stanford Canc Inst, Dept Neurosurg, Stanford, CA USA
[6] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
[7] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2120
引用
收藏
页码:E54 / E55
页数:2
相关论文
共 50 条
  • [1] Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
    Caressa Hui
    Vera Qu
    Jen-Yeu Wang
    Rie von Eyben
    Yu-Cheng Chang
    Po-Lin Chiang
    Chih-Hung Liang
    Jen-Tang Lu
    Gordon Li
    Melanie Hayden-Gephart
    Heather Wakelee
    Joel Neal
    Kavitha Ramchandran
    Millie Das
    Seema Nagpal
    Scott Soltys
    Nathaniel Myall
    Erqi Pollom
    Journal of Neuro-Oncology, 2022, 160 : 233 - 240
  • [2] Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
    Hui, Caressa
    Qu, Vera
    Wang, Jen-Yeu
    von Eyben, Rie
    Chang, Yu-Cheng
    Chiang, Po-Lin
    Liang, Chih-Hung
    Lu, Jen-Tang
    Li, Gordon
    Hayden-Gephart, Melanie
    Wakelee, Heather
    Neal, Joel
    Ramchandran, Kavitha
    Das, Millie
    Nagpal, Seema
    Soltys, Scott
    Myall, Nathaniel
    Pollom, Erqi
    JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (01) : 233 - 240
  • [3] Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Tozuka, Takehiro
    Noro, Rintaro
    Mizutani, Hideaki
    Kurimoto, Futoshi
    Hakozaki, Taiki
    Hisakane, Kakeru
    Naito, Tomoyuki
    Takahashi, Satoshi
    Taniuchi, Namiko
    Yajima, Chika
    Hosomi, Yukio
    Hirose, Takashi
    Minegishi, Yuji
    Okano, Tetsuya
    Kamio, Koichiro
    Yamaguchi, Tomoyoshi
    Seike, Masahiro
    LUNG CANCER, 2024, 191
  • [4] CARDIOVASCULAR EVENTS IN PATIENTS WITH EGFR-MUTANT NON-SMALL CELL LUNG CANCER ON OSIMERTINIB
    Peleg, Ariel
    Ibtida, Ishmam
    Liu, Jennifer
    Steingart, Richard
    Yu, Anthony
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3288 - 3288
  • [5] Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases
    Yang, T. Jonathan
    Wu, Abraham J.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 134 - 137
  • [6] Osimertinib in EGFR-mutant non-small cell lung carcinoma
    Lorenz, Judith
    PNEUMOLOGIE, 2023, 77 (11): : 847 - 847
  • [7] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [8] Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer
    Digumarthy, Subba R.
    Mendoza, Dexter P.
    Padole, Atul
    Chen, Tianqi
    Peterson, P. Gabriel
    Piotrowska, Zofia
    Sequist, Lecia, V
    CANCERS, 2019, 11 (09)
  • [9] Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
    Chen, Lanyi Nora
    Ma, Xin
    Herzberg, Benjamin
    Henick, Brian S.
    Biswas, Anup K.
    Acharyya, Swarnali
    Shu, Catherine A.
    ONCOLOGIST, 2024,
  • [10] Brain metastases in patients with EGFR-mutant non-small-cell lung cancer
    Rosell, Rafael
    Karachaliou, Niki
    LANCET RESPIRATORY MEDICINE, 2017, 5 (09): : 669 - 671